BDBM620204 (2R,3R,4R,5R,6R)-2-((1,8-dioxa-2-azaspiro[4.5]dec-2-en-3-yl)methyl)-4-(4- (2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,5-diol::US20230295182, Example 1.02

SMILES Cc1ccc(-c2cn(nn2)[C@H]2[C@@H](O)[C@@H](CO)O[C@H](CC3=NOC4(C3)CCOCC4)[C@@H]2O)c(F)c1F

InChI Key InChIKey=PDLXOWGSGXDNTC-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 620204   

TargetGalectin-3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM620204(US20230295182, Example 1.02 | (2R,3R,4R,5R,6R)-2-(...)
Affinity DataIC50: 84nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384 well plates are supplemented with 22.8 uL/well of biotinylated hG...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent

TargetGalectin-1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM620204(US20230295182, Example 1.02 | (2R,3R,4R,5R,6R)-2-(...)
Affinity DataIC50: 5.20E+3nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384 well plates are supplemented with 22.8 uL/well of biotinylated hG...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
US Patent